Chiome Bioscience (TSE:4583) Days Payable : 48.19 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Chiome Bioscience Days Payable?

Chiome Bioscience's average Accounts Payable for the three months ended in Mar. 2024 was 円38.4 Mil. Chiome Bioscience's Cost of Goods Sold for the three months ended in Mar. 2024 was 円72.6 Mil. Hence, Chiome Bioscience's Days Payable for the three months ended in Mar. 2024 was 48.19.

The historical rank and industry rank for Chiome Bioscience's Days Payable or its related term are showing as below:

TSE:4583' s Days Payable Range Over the Past 10 Years
Min: 39.92 Med: 88.1 Max: 226.41
Current: 51.39

During the past 13 years, Chiome Bioscience's highest Days Payable was 226.41. The lowest was 39.92. And the median was 88.10.

TSE:4583's Days Payable is ranked worse than
73.03% of 723 companies
in the Biotechnology industry
Industry Median: 148.78 vs TSE:4583: 51.39

Chiome Bioscience's Days Payable declined from Mar. 2023 (50.31) to Mar. 2024 (48.19). It may suggest that Chiome Bioscience accelerated paying its suppliers.

Chiome Bioscience Days Payable Historical Data

The historical data trend for Chiome Bioscience's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chiome Bioscience Days Payable Chart

Chiome Bioscience Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

69.25

54.26

43.93

39.92

44.75

Chiome Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															50.31	50.65	50.19	51.17	48.19

Competitive Comparison of Chiome Bioscience's Days Payable

For the Biotechnology subindustry, Chiome Bioscience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chiome Bioscience's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chiome Bioscience's Days Payable distribution charts can be found below:

* The bar in red indicates where Chiome Bioscience's Days Payable falls into.

Chiome Bioscience Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Chiome Bioscience's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (31.866	+	37.735)	/	2 )	/	283.869	*	365
=	34.8005					/	283.869	*	365
=	44.75

Chiome Bioscience's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (37.735	+	38.998)	/	2 )	/	72.646	*	365 / 4
=	38.3665					/	72.646	*	365 / 4
=	48.19

Chiome Bioscience Days Payable Related Terms

Thank you for viewing the detailed overview of Chiome Bioscience's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Chiome Bioscience (TSE:4583) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chiome Bioscience Inc (TSE:4583) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1, Honmachi, Shibuya-ku, Tokyo, JPN, 151-0071

Website

http://www.chiome.co.jp

Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Chiome Bioscience (TSE:4583) Headlines

No Headlines